Collection 專利 [0/70] 期刊論文 [161/161] 會議論文/會議摘要 [23/37] Siblings 伍素瑩 [53/74] 其他 [59/61] 夏克山 [77/157] 岳嶽 [29/34] 張仲明 [7/9] 張俊彥 [23/24] 張竣評 [21/38] 徐祖安 [170/241] 李秀珠 [76/108] 李靜琪 [24/28] 林書玉 [21/31] 洪明秀 [33/44] 潘秀玲(2009-2013) [16/17] 王文傑 [13/15] 王鴻俊 [7/7] 石全(2014-2017) [36/105] 童俊維 [25/25] 紀雅惠 [22/28] 翁紹華 [23/43] 莊宏 [1/1] 葉修華 [25/45] 葉燈光 [137/160] 蔣維棠 [43/99] 謝興邦 [180/261] 趙宇生(2002-2013) [120/279] 郭靜娟 [53/59] 鄒倫 [31/71] 陳志豪 [31/70] 陳新(2002-2015) [53/68] 顏婉菁 [6/8] 許明珠(1997-2001) [3/10] 陳淑貞(1998-2001) [3/11] 陳華鍵(1997-2001) [9/9] Community Statistics 近3年內發表的文件:28(10.45%) 含全文筆數:184(68.66%) 文件下載次數統計 下載大於0次:184(100.00%) 下載大於100次:178(96.74%) 檔案下載總次數:102882(1.76%) 最後更新時間: 2025-04-26 23:38 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Orally bioavailable and site-select... 增加細胞吞噬作用之方法 항암 경구 제제 Poly heterocyclic conjugates and th... Poly heterocyclic conjugates and th... 多雜環小分子藥物偶合物及其用途 Benzimidazole compounds and use the... Benzimidazole compounds and use the... 苯并咪唑化合物及其在製備治療阿茲海默症或亨丁頓氏症的藥物中的用途 苯並咪唑化合物及其在製備治療阿茲海默症或亨丁頓氏症的藥物中的用途

跳至: (選擇年份) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-25 / 268. (共11頁) 1 2 3 4 5 6 7 8 9 10 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2025-02-27	Orally bioavailable and site-selective covalent STING inhibitor derived from a macrocyclic marine diterpenoid	Journal of Medicinal Chemistry. 2025 Feb 27;Article in Press.
2025-02	Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin[Erratum:Biochemical Pharmacology. 2023 Jul 20;215:Article number 115688.]	Biochemical Pharmacology. 2025 Feb;232:Article number 116753.
2025-01-05	Integrating ultrabright polymer dots and stereo NIR-II imager for assessing anti-angiogenic drugs in oral cancer model	Journal of Cellular and Molecular Medicine. 2025 Jan 05;29(1):Article number e70324.
2025-01	Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models	Pharmacological Research. 2025 Jan;211:Article number 107556.
2024-11-21	Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia	Cell Chemical Biology. 2024 Nov 21;31(11):1885-1898.e10.
2024-11	DBPR116, a prodrug of BPRMU191, in combination with naltrexone as a safer opioid analgesic than morphine via peripheral administration	Journal of Medicinal Chemistry. 2024 Nov 14;67(21):19777-19790.
2024-06-01	Discovery of a long half-life AURKA inhibitor to treat MYC-amplified solid tumors as a monotherapy and in combination with everolimus	Molecular Cancer Therapeutics. 2024 Jun 01;23(6):766-779.
2024-05-30	Poly heterocyclic conjugates and their pharmaceutical uses	ZA2022/12959/2024-05-30
2024-03-26	Heterocyclic compounds and use thereof	NZ730195/2024-03-26
2024-02-16	Postfermented tea extract potently alleviates glucose metabolism disorders in vitro and in vivo	ACS Food Science and Technology. 2024 Feb 16;4(2):479-490.
2024-01-23	Poly heterocyclic conjugates and their pharmaceutical uses	US11878986/2024-01-23
2024-01-14	Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease	SG11202101274X/2024-01-14
2023-12-19	Heterocyclic compounds and use thereof	CA2962329/2023-12-19
2023-09-26	Composto de fórmula (i) e composição farmacêutica	BR112017005713/2023-09-26
2023-08-31	Dipicolylamine derivatives and their pharmaceutical uses	IN448770/2023-08-31
2023-08-15	Composto e composição farmacêutica	BR112016027078-9/2023-08-15
2023-07-20	Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin	Biochemical Pharmacology. 2023 Jul 20;215:Article number 115688.
2023-06-01	增加細胞吞噬作用之方法	TWI804339/2023-06-01
2023-04-21	多雜環小分子藥物偶合物及其用途	TWI799896/2023-04-21
2023-03-08	헤테로사이클릭 화합물과 이의 용도	KR10-2509431/2023-03-08
2023-03-03	Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease	IN424040/2023-03-03
2023-02-10	Heterocyclic compounds and use thereof	IN421151/2023-02-10
2023-02-07	Development of furanopyrimidine-based orally active third-generation EGFR inhibitors for the treatment of non-small cell lung cancer	Journal of Medicinal Chemistry. 2023 Feb 7;66(4):2566-2588.
2023-01-27	苯並咪唑化合物及其在製備治療阿茲海默症或亨丁頓氏症的藥物中的用途	HK40053325/2023-01-27
2023-01-26	苯并咪唑化合物及其在製備治療阿茲海默症或亨丁頓氏症的藥物中的用途	J/006659/2023-01-26

顯示項目1-25 / 268. (共11頁) 1 2 3 4 5 6 7 8 9 10 > >> 每頁顯示[10|25|50]項目